Team:Marburg
From 2013.igem.org
m |
m |
||
Line 4: | Line 4: | ||
{{:Team:Marburg/Template:ContentStart}} | {{:Team:Marburg/Template:ContentStart}} | ||
- | The | + | The use of proteins in medical treatment and diagnosis is steadily increasing. Many pharmaceutically relevant proteins, such as antibodies, have a complex biological structure with specific posttranslational modifications. Furthermore, these proteins need to be highly pure because of their use in diagnostics and treatment. Therefore, a major challenge is the development of systems that produce highly pure, posttranslational modified pharmaceutical proteins - best at low costs. |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
+ | Recently, the sunlight-driven microalgae Phaeodactylum tricornutum has been established as an elegant tool for the production of proteins (Phaectory). A major - however yet unchallenged - advantage of this system is the production of advanced proteins with specific posttranslational modifications. A further major advantage is the ability of their direct secretion into the medium, which allows easy purification with low effort and costs. Our mission is to challenge Phaectory as a system for the convenient production of antibodies. We want to take advantage of the excellent secretion and ability of posttranslational modification and make the system accessible to following iGEM teams. | ||
[[File:Fabrik_horizontal.png|1000px|center]] | [[File:Fabrik_horizontal.png|1000px|center]] | ||
- | <html> | + | <html><div class="home"> |
- | <div class="home"> | + | |
<div class="home_youtube"> | <div class="home_youtube"> | ||
<iframe width="475" height="297" src="//www.youtube.com/embed/xpgl8yd0lNM" frameborder="0" allowfullscreen></iframe> | <iframe width="475" height="297" src="//www.youtube.com/embed/xpgl8yd0lNM" frameborder="0" allowfullscreen></iframe> | ||
Line 35: | Line 25: | ||
<img src="https://static.igem.org/mediawiki/2013/1/1a/Mr_igem_home_cycle.png" /></a> | <img src="https://static.igem.org/mediawiki/2013/1/1a/Mr_igem_home_cycle.png" /></a> | ||
</div> | </div> | ||
- | </div> | + | </div><div style="clear:both;"></div></div> |
- | </div> | + | |
</html> | </html> | ||
{{:Team:Marburg/Template:ContentEnd}} | {{:Team:Marburg/Template:ContentEnd}} | ||
{{:Team:Marburg/Template:Footer}} | {{:Team:Marburg/Template:Footer}} |
Revision as of 11:03, 22 September 2013
Antibodies produced by sunlight
The use of proteins in medical treatment and diagnosis is steadily increasing. Many pharmaceutically relevant proteins, such as antibodies, have a complex biological structure with specific posttranslational modifications. Furthermore, these proteins need to be highly pure because of their use in diagnostics and treatment. Therefore, a major challenge is the development of systems that produce highly pure, posttranslational modified pharmaceutical proteins - best at low costs.
Recently, the sunlight-driven microalgae Phaeodactylum tricornutum has been established as an elegant tool for the production of proteins (Phaectory). A major - however yet unchallenged - advantage of this system is the production of advanced proteins with specific posttranslational modifications. A further major advantage is the ability of their direct secretion into the medium, which allows easy purification with low effort and costs. Our mission is to challenge Phaectory as a system for the convenient production of antibodies. We want to take advantage of the excellent secretion and ability of posttranslational modification and make the system accessible to following iGEM teams.